GMP & Cold Chain Compliance for Probiotic Health Supplement in Indonesia

Getting a probiotic strain accepted by BPOM is only half the work. A probiotic supplement is a product whose active ingredient is alive, and BPOM’s rules say so directly: storage and transport must keep the organisms viable at the count printed on the label, through to the end of shelf life. That obligation lands on the factory that makes the product, the importer that brings it in, and every warehouse and vehicle in between.

This guide covers the manufacturing and post-approval side of that obligation: which GMP certificate BPOM accepts (CPOB, CPOTB or a food-GMP route), what foreign manufacturers must show, how storage conditions are set, what the cold chain has to prove, how raw materials are reviewed, and what continues after the marketing authorisation is issued. For strain assessment, product categorisation and CFU claims, see our companion guide to probiotic supplement registration with BPOM. 

Key Takeaways

• BPOM does not require CPOB specifically. Health supplements can be made under CPOB, CPOTB, or a food-GMP (CPPOB) permit with BPOM approval to produce supplements, and the certificate must match the dosage form (PerBPOM 32/2022, Art. 3).
• The cold chain is a legal obligation, not just good practice. PerBPOM 17/2025 makes the business actor responsible for keeping viable counts at label claim through storage, transport and the whole distribution chain.
• Stability data set the storage condition. The default is Climatic Zone IVb (30°C/75% RH); refrigerated probiotics need long-term data at the labelled condition and accelerated testing at least 15°C above it (PerBPOM 6/2025).
• Imports are checked at both ends. The foreign manufacturer’s GMP certificate must come from the origin-country authority and be apostilled or legalised, and BPOM audits the Indonesian importer’s distribution facility before registration.
• Halal applies from 18 October 2026. Health supplements, including imports, fall under Indonesia’s mandatory halal certification phase, which puts capsule shells, carriers and culture growth media under review.

Which Regulations Apply to Probiotic Supplement Manufacturing?

Five BPOM regulations do most of the work, with halal rules sitting alongside them:

Why Manufacturing Compliance Is a Separate Risk Layer

BPOM describes probiotics as different from other supplements because the active ingredient is a living microorganism, which is why PerBPOM 17/2025 sets specific requirements for safety, benefit, quality and storage conditions. Heat, humidity and oxygen do not just degrade a probiotic; they kill it, and the damage shows up as a lower viable count rather than a visible defect. A product can pass strain assessment and still fail in the market if the site that makes it, or the chain that moves it, cannot protect that count.

Which GMP Certificate Does BPOM Accept for Probiotic Supplements?

There is no CPOB-only rule for probiotics. Under Article 3 of PerBPOM 32/2022, good manufacturing practice for health supplements can be demonstrated through any of three routes, and the certificate must cover the dosage form being registered (capsules, tablets, powder sachets, liquid drops and so on):

• CPOB (Cara Pembuatan Obat yang Baik) — pharmaceutical GMP, held by a pharmaceutical manufacturer. A pharmaceutical plant making supplements with non-drug ingredients also needs BPOM approval to share its drug production facility with health supplements.
• CPOTB (Cara Pembuatan Obat Tradisional yang Baik) — GMP for traditional medicine manufacturers (IOT and UKOT), a common route for domestic supplement producers.
• CPPOB plus supplement production approval — a processed-food manufacturer with a CPPOB permit can make supplements once BPOM approves supplement production in that facility. The regulation treats that approval as proof the site applies CPOTB aspects.

The same rule applies to contract manufacturing. The contract manufacturer must hold the right certificate for the dosage form, the contract must be notarised and set out how GMP responsibilities are split, and the company commissioning the work (the contract giver), as marketing authorisation holder, remains primarily responsible for safety, benefit and quality. Adding a back-up production site is registered as a variation. A marketing company without its own plant can hold the registration, but it needs a pharmacist (apoteker) as technical responsible person, compliant storage, and a quality-testing laboratory that meets CPOTB requirements.

A GMP certificate is issued per dosage form, not per ingredient class, so it does not tell you whether a site is ready for live cultures. Before you sign with a manufacturer, check live-culture capability specifically:

• Containment and segregation of culture handling, so viable organisms (spore-formers such as Bacillus in particular) cannot cross-contaminate other product lines, backed by cleaning validation.
• Humidity control in dispensing, blending and filling areas, since moisture uptake is one of the fastest routes to viability loss in dry probiotic powders.
• A quality control laboratory with validated methods to count and identify the declared strains. PerBPOM 17/2025 asks for the qualitative and quantitative methods used, including how the species in the finished product are confirmed to match the registration.
• Qualified cold storage for incoming freeze-dried cultures and finished goods, with temperature records.

Imported Probiotics: What BPOM Accepts as GMP Evidence

A foreign manufacturer cannot hold an Indonesian marketing authorisation itself. Imported health supplements are registered by an Indonesian importer, and BPOM checks both ends of the supply chain:

• The foreign GMP certificate must be issued by the competent government authority in the country of origin (or a body it has designated, confirmed by letter), have at least one year of validity remaining, and be apostilled or legalised by the Indonesian embassy. If it shows no expiry date, the importer submits inspection documents from the last two years or a certificate issued within two years of registration.
• Food-GMP manufacturers are not excluded, but the importer must submit the site master file and request a GMP equivalence assessment, which BPOM approves or rejects. BPOM may also inspect a foreign site on location.
• The importer’s distribution facility is audited by BPOM, and the resulting importer recommendation is a prerequisite for opening a registration account and registering products. For a refrigerated probiotic, expect that facility to have to demonstrate it can hold the labelled storage condition.
• The agency appointment must grant the importer the right to register, import and distribute. Only one importer can be appointed for the same product, formula and benefit from the same manufacturer, and an imported product’s marketing authorisation runs only as long as that appointment, up to five years.
• Labels on imported finished products must already carry the approved Indonesian labelling when the goods enter Indonesia.

Products can be imported as finished goods or in bulk for local packaging. Bulk imported by a marketing company requires an agreement with a local packer holding GMP for that dosage form.

Setting the Storage Condition: Where Stability Data Meets the Cold Chain

The cold chain you have to run is decided by your stability data. PerBPOM 32/2022 sets Climatic Zone IVb (30°C, 75% relative humidity) as the default stability condition for health supplements; if a product is not stable at Zone IVb, the business actor must justify that and test at conditions that suit the product.

PerBPOM 6/2025, BPOM’s stability testing guideline for supplements, shows how. BPOM’s socialisation material names probiotic supplements among products whose formulas are unsuited to high-temperature storage and which therefore need long-term (real-time) stability data. For products kept at low temperature, the six-month accelerated study must run at least 15°C above the labelled storage temperature: for a refrigerated product, 25°C ± 2°C at 60% ± 5% RH. The long-term condition is then declared on the label together with the shelf life.

Two consequences follow. The labelled storage condition becomes a commitment your whole distribution chain must honour. And your accelerated and supporting data are also the evidence you will use to judge what a temperature excursion means for a batch, so design the stability programme with excursion assessment in mind, not only registration. The CFU-claim side of stability is covered in our registration guide.

Cold Chain Compliance: What the Regulation Requires and How to Prove It

PerBPOM 17/2025 is explicit about the outcome. Storage and transport must keep the microorganisms alive at the count declared on the label; storage temperatures must follow the stability results and appear on the label; and the business actor must guarantee that the product meets safety, benefit and quality requirements throughout the distribution chain, taking account of the critical factors that affect total viable count.

The regulation sets the outcome rather than the monitoring method, so the evidence is up to you. In practice, continuous temperature records are the only convincing way to show the labelled count was protected. Map every hand-off where control can break:

• Release from the manufacturer’s warehouse and loading for export.
• Air or ocean freight, including transhipment points.
• Port dwell time and customs clearance, where cargo can sit without active monitoring.
• The importer’s warehouse, which is the facility BPOM audits before registration.
• Distributor storage and last-mile delivery to pharmacies, retailers and e-commerce fulfilment centres.
• Storage at the point of sale, where the label instruction has to be followed.

A gap in the record matters as much as a recorded excursion. If post-market sampling finds a low count, an unexplained gap leaves you with no way to show the loss did not happen on your watch. Define in advance, backed by stability data, which excursions are acceptable and how affected stock is assessed, quarantined or released.

If you can formulate for Zone IVb instead, through strain selection, low-water-activity processing and high-barrier packaging such as aluminium blisters with desiccant, you remove most of this exposure.

Raw Materials, Excipients and Source Documentation

Every ingredient in a probiotic formula (the freeze-dried culture, cryoprotectants and carriers, prebiotic fibres, flow agents, capsule shells) must meet BPOM’s raw material rules. PerBPOM 32/2022 sets three baseline requirements:

• Raw materials must comply with the Indonesian Pharmacopoeia, the Indonesian Herbal Pharmacopoeia, another country’s pharmacopoeia or a recognised scientific reference.
• Excipients must be ones permitted for use in health supplements.
• Active ingredients and excipients that are not of plant origin need source-of-origin documentation, which BPOM evaluates. For probiotics, that typically covers the culture itself and animal- or dairy-derived materials such as gelatin capsule shells or milk-based carriers.

PerBPOM 26/2025 adds a risk-based layer. Where BPOM’s risk assessment finds that a natural medicine, supplement, quasi-drug or cosmetic could be harmful if made with non-pharmaceutical materials, its raw materials must meet pharmaceutical-grade standards (the Indonesian Pharmacopoeia or another internationally recognised pharmacopoeia), and BPOM publishes a list of the materials concerned. Check your formula against that list before you finalise specifications.

For liquid formats, BPOM’s risk-mitigation guidance on ethylene glycol and diethylene glycol applies where solvents such as propylene glycol, polyethylene glycol, glycerin or sorbitol solution are used: expect to provide contaminant test results for the solvent and the finished product. Finished-product contaminant limits, including microbial contamination, follow PerBPOM 24/2023. A missing certificate of analysis or source document for a single minor excipient can hold up an otherwise complete dossier.

Halal Certification: The October 2026 Deadline Reaches Probiotics

Under Government Regulation No. 42 of 2024, health supplements are among the product categories that must be halal-certified from 18 October 2026, and BPJPH has confirmed this phase covers imported products. BPJPH Regulation No. 4 of 2026, issued on 10 August 2026, sets out how conformity of foreign halal products entering Indonesia is assured.

For probiotic supplements, halal review tends to focus on the same materials BPOM asks about: gelatin capsule shells, dairy- or animal-derived carriers and cryoprotectants, and the growth media used to ferment the culture. Aligning your BPOM source documentation with your halal documentation from the start avoids chasing suppliers twice.

Strain Identity and Traceability in Production

Strain assessment belongs to registration, but three of its requirements matter on the production floor because they must stay true batch after batch:

• Culture collection deposit. Every strain, whether isolated in Indonesia or abroad, must be deposited in a reputable national or international culture collection (such as ATCC or DSMZ) under proper storage procedures.
• Identity you can re-confirm. Strains are identified by combined phenotypic and genotypic methods (16S rRNA gene sequencing for bacteria, 18S rRNA for eukaryotes such as yeasts) using whole genome sequencing, PCR and sequencing, or another validated method. Your QC methods must be able to confirm that the species in the finished product match the registration.
• Source of acquisition. The quality dossier records where the strain came from (for example, isolation from human breast milk) and/or the strain producer or licence holder.

Safety data at assessment stage include an antibiotic resistance profile, whole-genome evidence that the strain carries no transferable antibiotic resistance genes, and evidence that it does not produce toxins. The manufacturing lesson is seed-lot discipline: keep master and working cell banks controlled so the strain produced at scale is demonstrably the strain that was assessed.

Labelling: Strain Identity, CFU and Storage Instructions

PerBPOM 17/2025 requires probiotic labels to show the genus, species and strain in correct nomenclature; the number of live organisms, stable to the end of shelf life and expressed in colony forming units (CFU); directions for use consistent with the clinical data; and specific storage conditions where the product needs a particular temperature.

Under PerBPOM 32/2022, label information must be in Bahasa Indonesia using Latin script and Arabic numerals, with storage conditions among the mandatory elements. Imported finished products must carry the approved labelling when they enter Indonesia, so relabelling after arrival is not a fallback.

Claims must match the evaluated strain and its data. Health supplements can carry general, functional or disease-risk-reduction claims, but not claims to prevent or treat disease, and PerBPOM 17/2025 states that a probiotic tested against standard therapy for treating a disease (Phase III) cannot be categorised as a health supplement.

After Approval: Ongoing Obligations for Probiotic Supplement Holders

• Retained samples of every batch, in sufficient quantity, kept for at least one year after expiry (PerBPOM 32/2022, Art. 71).
• Post-market monitoring of safety and quality, including adverse events, for products on the market.
• Variations for changes such as an alternative production site, formula or labelling, with approved changes implemented within six months.
• Re-evaluation. BPOM can reassess registered probiotic products as science develops (PerBPOM 17/2025, Art. 11) and, based on risk assessment, order recalls or freeze or cancel marketing authorisations. Authorisations issued before PerBPOM 17/2025 remain valid until they expire.
• Keeping the authorisation alive. A marketing authorisation can be revoked if the GMP certificate is revoked, if nothing is produced or imported within one year of approval, or if production or import stops for two consecutive years. Re-registration must be filed between 180 days and one day before expiry.

Before You Submit: Practical Checks

Check each strain against BPOM’s list of permitted probiotic strains rather than assuming either novelty or prior clearance. A strain not on the list needs its own assessment before registration, which BPOM must decide within 85 working days of receiving the application. That is a registration question, covered in our companion guide.

When you clarify technical points with BPOM directly, keep a formal record, such as signed or emailed minutes of meeting, so you have evidence if guidance is later interpreted differently. During evaluation, PerBPOM 32/2022 also provides a formal written hearing (dengar pendapat), available once before a decision is issued.

Get Your Manufacturing and Supply Chain Ready for BPOM Review

Strain approval only clears part of the path to market. GMP scope, importer facility readiness, stability-based storage conditions, cold chain evidence and raw material documentation are where otherwise approvable probiotic products stall.

Product Registration Indonesia supports health supplement registration, license holder services, importation support and halal certification. Talk to our Health Supplements team via form below about mapping your manufacturing site, cold chain and ingredient documentation against current BPOM requirements before you submit